Biomea Fusion, Inc.
BMEA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $118 | $103 | $63 | $28 |
| G&A Expenses | $26 | $24 | $21 | $14 |
| SG&A Expenses | $26 | $24 | $21 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $144 | $126 | $84 | $42 |
| Operating Income | -$144 | -$126 | -$84 | -$42 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $6 | $9 | $2 | $0 |
| Pre-Tax Income | -$138 | -$117 | -$82 | -$42 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$138 | -$117 | -$82 | -$42 |
| % Margin | – | – | – | – |
| EPS | -3.83 | -3.44 | -2.8 | -1.74 |
| % Growth | -11.3% | -22.9% | -60.9% | – |
| EPS Diluted | -3.83 | -3.44 | -2.8 | -1.74 |
| Weighted Avg Shares Out | 36 | 34 | 29 | 24 |
| Weighted Avg Shares Out Dil | 36 | 34 | 29 | 24 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $9 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $1 | $0 |
| EBITDA | -$142 | -$125 | -$83 | -$41 |
| % Margin | – | – | – | – |